Brookings Institute Hosts Forum on Drug Development for Neglected Diseases
On April 24, the Brookings Institution in Washington D.C. convened a forum on Drug Development for Neglected Diseases, focusing on
On April 24, the Brookings Institution in Washington D.C. convened a forum on Drug Development for Neglected Diseases, focusing on
It’s hard to imagine how a Rwandan woman with AIDS might be considered lucky, but in a way, she is.
More than 50 years after the introduction of effective chemotherapy for tuberculosis, the disease remains unconquered and in many resource-poor
Morning Edition 11:00 AM EST ANCHORS: STEVE INSKEEP REPORTERS: BRENDA WILSON HOST: STEVE INSKEEP One-third of the world’s population is
Three Grants Announced at Columbia University Symposium Tracking Progress in Battle Against Disease Infecting One-Third of the World NEW YORK
LONDON (Reuters) – The governments of Britain, the Netherlands and Ireland said on Tuesday they were giving $14.2 million (8
Project Aims to Streamline and Shorten Drug Development for Tuberculosis New York, NY and Waltham, MA., February 21, 2006 –
For the first time in decades, pharma has tuberculosis drugs in the pipeline. But it will take more than new
An international partnership yesterday laid out a plan to treat 50 million people with tuberculosis and save 14 million lives
Pursuing drugs for neglected diseases is not a traditional part of the pharmaceutical company portfolio. But Paul Herrling of Novartis